The global healthcare nanotechnology market is expected to expand at a compound annual growth rate of 9.6 percent between 2017 and 2022, according to a Persistence Market Research report, and the North American region will have the greatest market share.
Here are four things to know.
1. North America led the global healthcare nanotechnology market in 2016 and is expected to grow at a compound annual growth rate of 10 percent during the forecasted period.
2. The Asia-Pacific region excluding Japan is the second fastest-growing region, and is expected to expand at a compound annual growth rate of 9.8 percent over the forecasted period.
3. The active implantable devices segment is the fastest growing segment dominating the global market by product type; the biochips segment is forecasted to rise at a compound annual growth rate of 9.6 percent.
4. Key players in the global healthcare nanotechnology market include Thermo Fisher Scientific, Stryker, Smith & Nephew, PerkinElmer, Merck, GE Global Research, Ferro Corp, AstraZeneca, Abbott Laboratories and 3M.
More articles on surface technology:
The future is PEEK - Solvay's Global Marketing Manager discusses the benefits of polymers
Nanovis' new spinal implant technology may reduce antibiotic resistance — here's how